Lipella Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LIPO and buy or sell other stocks, ETFs, and their options commission-free!About LIPO
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent.
CEOJonathan Kaufman
CEOJonathan Kaufman
Employees7
Employees7
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2005
Founded2005
Employees7
Employees7
LIPO Key Statistics
Market cap2.96M
Market cap2.96M
Price-Earnings ratio-3.97
Price-Earnings ratio-3.97
Dividend yield—
Dividend yield—
Average volume434.56K
Average volume434.56K
High today$0.309
High today$0.309
Low today$0.309
Low today$0.309
Open price$0.309
Open price$0.309
Volume380.00
Volume380.00
52 Week high$1.50
52 Week high$1.50
52 Week low$0.2804
52 Week low$0.2804
Stock Snapshot
With a market cap of 2.96M, Lipella Pharmaceuticals(LIPO) trades at $0.31. The stock has a price-to-earnings ratio of -3.97.
On 2025-12-13, Lipella Pharmaceuticals(LIPO) stock traded between a low of $0.31 and a high of $0.31. Shares are currently priced at $0.31, which is 0.0% above the low and 0.0% below the high.
The Lipella Pharmaceuticals(LIPO)'s current trading volume is 380, compared to an average daily volume of 434.56K.
During the past year, Lipella Pharmaceuticals(LIPO) stock moved between $0.28 at its lowest and $1.50 at its peak.
During the past year, Lipella Pharmaceuticals(LIPO) stock moved between $0.28 at its lowest and $1.50 at its peak.
People also own
Based on the portfolios of people who own LIPO. This list is generated using Robinhood data, and it’s not a recommendation.